Ertava 1 g Powder for solution for injection or infusion
PDF Leaflet Revision Date: 30.09.2025
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of moderate to severe infections in adults and children.
Dosage (summary)
Adults: 1 g once daily; Children 3 months-12 years: 15 mg/kg twice daily (max 1 g/day).
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Safety in pregnancy and breastfeeding not established.
Key Drug Interactions
- Valproic acid
Contraindications
- Hypersensitivity to ertapenem
- Hypersensitivity to beta-lactam antibiotics
- Bacterial meningitis
- Infants under 3 months
Common side effects
- Diarrhoea
- Nausea
- Vomiting
- Headache
- Dizziness
Counselling Points
- Report any allergic reactions
- Monitor for signs of superinfection
- Avoid use with valproic acid
Serious warnings
- Serious hypersensitivity reactions
- Antibiotic-associated colitis
- Seizures
Important Disclaimer
The Ertava 1 g Powder for solution for injection or infusion professional information leaflet below is the property of Abex Pharmaceutica and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
